世界の良性前立腺過形成（BPH）治療市場予測（～2024年）

• 英文タイトル：Global Benign Prostatic Hyperplasia (BPH) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR09D3807
• 出版社/出版日：GlobalInfoResearch / 2019年9月18日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、121ページ
• 納品方法：Eメール
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、良性前立腺過形成（BPH）治療の世界市場について調べ、まとめました。種類別セグメントは、薬、デバイス等、用途別セグメントは、病院、診療所、その他等に区分しました。良性前立腺過形成（BPH）治療の世界市場概観、企業動向、企業別良性前立腺過形成（BPH）治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・良性前立腺過形成（BPH）治療の市場概観
・良性前立腺過形成（BPH）治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・良性前立腺過形成（BPH）治療の企業別販売動向、市場シェア、市場集中度、競争動向
・良性前立腺過形成（BPH）治療の世界市場規模
・良性前立腺過形成（BPH）治療の北米市場分析（アメリカ、カナダ、メキシコ等）
・良性前立腺過形成（BPH）治療のアメリカ市場規模推移
・良性前立腺過形成（BPH）治療のカナダ市場規模推移
・良性前立腺過形成（BPH）治療のメキシコ市場規模推移
・良性前立腺過形成（BPH）治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・良性前立腺過形成（BPH）治療のドイツ市場規模推移
・良性前立腺過形成（BPH）治療のイギリス市場規模推移
・良性前立腺過形成（BPH）治療のロシア市場規模推移
・良性前立腺過形成（BPH）治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・良性前立腺過形成（BPH）治療の日本市場規模推移
・良性前立腺過形成（BPH）治療の中国市場規模推移
・良性前立腺過形成（BPH）治療の韓国市場規模推移
・良性前立腺過形成（BPH）治療のインド市場規模推移
・良性前立腺過形成（BPH）治療の東南アジア市場規模推移
・良性前立腺過形成（BPH）治療の南米市場分析（ブラジル、アルゼンチン等）
・良性前立腺過形成（BPH）治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・良性前立腺過形成（BPH）治療の種類別分析/販売量、売上、市場シェア（薬、デバイス）
・良性前立腺過形成（BPH）治療の用途別分析/市場規模（病院、診療所、その他）
・良性前立腺過形成（BPH）治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・良性前立腺過形成（BPH）治療の販売チャネル・代理店・貿易業者・ディーラー分析

Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate. Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. Complications can include urinary tract infections, bladder stones, and chronic kidney problems.

Scope of the Report:
The global Benign Prostatic Hyperplasia (BPH) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Benign Prostatic Hyperplasia (BPH) Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Benign Prostatic Hyperplasia (BPH) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Benign Prostatic Hyperplasia (BPH) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
Pfizer
Sanofi
GlaxoSmithKline
Boston Scientific
Teleflex
Cardinal Health
Allergan
Teva Pharmaceutical
Mylan
Eli Lilly

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Drugs
Devices

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

レポート目次

Table of Contents

1 Benign Prostatic Hyperplasia (BPH) Treatment Market Overview
1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment
1.2 Classification of Benign Prostatic Hyperplasia (BPH) Treatment by Types
1.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Types in 2018
1.2.3 Drugs
1.2.4 Devices
1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Market by Application
1.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Benign Prostatic Hyperplasia (BPH) Treatment Market by Regions
1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Benign Prostatic Hyperplasia (BPH) Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Benign Prostatic Hyperplasia (BPH) Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Benign Prostatic Hyperplasia (BPH) Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Benign Prostatic Hyperplasia (BPH) Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Benign Prostatic Hyperplasia (BPH) Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Benign Prostatic Hyperplasia (BPH) Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Sanofi
2.2.1 Business Overview
2.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Boston Scientific
2.4.1 Business Overview
2.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Teleflex
2.5.1 Business Overview
2.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Cardinal Health
2.6.1 Business Overview
2.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Allergan
2.7.1 Business Overview
2.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Allergan Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharmaceutical
2.8.1 Business Overview
2.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mylan
2.9.1 Business Overview
2.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mylan Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Eli Lilly
2.10.1 Business Overview
2.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Competition, by Players
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Benign Prostatic Hyperplasia (BPH) Treatment Players Market Share
3.2.2 Top 10 Benign Prostatic Hyperplasia (BPH) Treatment Players Market Share
3.3 Market Competition Trend
4 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size by Regions
4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Market Share by Regions
4.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
5 North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries
5.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
5.2 USA Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
6 Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries
6.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
6.2 Germany Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
6.4 France Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries
7.1 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
7.2 China Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
7.5 India Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
8 South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries
8.1 South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
8.2 Brazil Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Benign Prostatic Hyperplasia (BPH) Treatment by Countries
9.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
10 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Segment by Type
10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Forecast by Type (2019-2024)
10.3 Drugs Revenue Growth Rate (2014-2024)
10.4 Devices Revenue Growth Rate (2014-2024)
11 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Segment by Application
11.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Application (2014-2019)
11.2 Benign Prostatic Hyperplasia (BPH) Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Forecast (2019-2024)
12.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Size Forecast (2019-2024)
12.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Market Forecast by Regions (2019-2024)
12.3 North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
12.6 South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Benign Prostatic Hyperplasia (BPH) Treatment Picture
Table Product Specifications of Benign Prostatic Hyperplasia (BPH) Treatment
Table Global Benign Prostatic Hyperplasia (BPH) Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Types in 2018
Figure Drugs Picture
Figure Devices Picture
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Application (2014-2024)
Figure Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Pfizer Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Sanofi Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Boston Scientific Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teleflex Basic Information, Manufacturing Base and Competitors
Table Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Teleflex Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Cardinal Health Basic Information, Manufacturing Base and Competitors
Table Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Cardinal Health Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Allergan Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Teva Pharmaceutical Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Mylan Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Type and Applications
Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Players (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Players in 2017
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share in 2018
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Regions in 2018
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
Table North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries in 2018
Figure USA Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries in 2018
Figure Germany Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure UK Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure France Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries in 2018
Figure China Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure India Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Countries (2014-2019)
Table South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries in 2018
Figure Brazil Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue and Growth Rate (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Type (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Type in 2019
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Forecast by Type (2019-2024)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share Forecast by Type (2019-2024)
Figure Global Drugs Revenue Growth Rate (2014-2019)
Figure Global Devices Revenue Growth Rate (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue by Application (2014-2019)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Share by Application in 2019
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Forecast by Application (2019-2024)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
Figure Europe Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
Figure South America Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Revenue Market Forecast (2019-2024)

以下、関連資料のご紹介

世界の慢性リンパ性白血病（CLL）治療市場予測（～2024年）

Global Chronic Lymphocytic Leukemia (CLL) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3847 2019年9月18日 120Pages
本調査レポートは、慢性リンパ性白血病（CLL）治療の世界市場について調べ、まとめました。種類別セグメントは、CLLの初期治療、CLLの二次治療等、用途別セグメントは、大人用、子供用等に区分しました。慢性リンパ性白血病（CLL）治療の世界市場概観、企業動向、企業別慢性リンパ性白血病（CLL）治療シェア...

世界の物質使用障害（SUD）治療市場予測（～2024年）

Global Substance Use Disorders (SUDs) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4310 2019年9月18日 115Pages
本調査レポートは、物質使用障害（SUD）治療の世界市場について調べ、まとめました。種類別セグメントは、オピオイド中毒、タバコ/ニコチン中毒、アルコール依存症等、用途別セグメントは、病院及びクリニック、住宅（病院以外）等に区分しました。物質使用障害（SUD）治療の世界市場概観、企業動向、企業別物質使用...

世界の腎性全身性線維症（NSF）治療市場予測（～2024年）

Global Nephrogenic Systemic Fibrosis (NSF) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4156 2019年9月18日 115Pages
本調査レポートは、腎性全身性線維症（NSF）治療の世界市場について調べ、まとめました。種類別セグメントは、血液レオロジー剤、免疫調節薬、アルキル化剤、キナーゼ阻害剤、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腎性全身性線維症（NSF）治療の世界市場概観、企業動向、企業別腎性...

世界の腱炎治療市場予測（～2024年）

Global Tendinitis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4320 2019年9月18日 124Pages
本調査レポートは、腱炎治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。腱炎治療の世界市場概観、企業動向、企業別腱炎治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米...

世界のアナフィラキシー治療市場予測（～2024年）

Global Anaphylaxis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3773 2019年9月18日 116Pages
本調査レポートは、アナフィラキシー治療の世界市場について調べ、まとめました。種類別セグメントは、経口、非経口、その他等、用途別セグメントは、食物アレルギー、花粉アレルギー、ホコリダニアレルギー、その他等に区分しました。アナフィラキシー治療の世界市場概観、企業動向、企業別アナフィラキシー治療シェア、市...

世界の髄膜炎菌感染症治療市場予測（～2024年）

Global Meningococcal Infections Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4126 2019年9月18日 101Pages
本調査レポートは、髄膜炎菌感染症治療の世界市場について調べ、まとめました。種類別セグメントは、抗生物質、グルココルチコイド、プロテインC濃縮物等、用途別セグメントは、病院、診療所、その他等に区分しました。髄膜炎菌感染症治療の世界市場概観、企業動向、企業別髄膜炎菌感染症治療シェア、市場規模推移、市場規...

世界の舞踏病治療市場予測（～2024年）

Global Chorea Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3845 2019年9月18日 136Pages
本調査レポートは、舞踏病治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法等、用途別セグメントは、病院、診療所、その他等に区分しました。舞踏病治療の世界市場概観、企業動向、企業別舞踏病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、...

世界のレフサム病治療市場予測（～2024年）

Global Refsum Disease Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4255 2019年9月18日 119Pages
本調査レポートは、レフサム病治療の世界市場について調べ、まとめました。種類別セグメントは、手術療法、薬物療法等、用途別セグメントは、病院、診療所、その他等に区分しました。レフサム病治療の世界市場概観、企業動向、企業別レフサム病治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域...

世界のダンピング症候群治療市場予測（～2024年）

Global Dumping Syndrome Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D3928 2019年9月18日 124Pages
本調査レポートは、ダンピング症候群治療の世界市場について調べ、まとめました。種類別セグメントは、薬物療法、外科療法等、用途別セグメントは、病院、診療所、その他等に区分しました。ダンピング症候群治療の世界市場概観、企業動向、企業別ダンピング症候群治療シェア、市場規模推移、市場規模予測（2019年-20...

世界の天疱瘡治療市場予測（～2024年）

Global Pemphigus Vulgaris Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4191 2019年9月18日 116Pages
本調査レポートは、天疱瘡治療の世界市場について調べ、まとめました。種類別セグメントは、経口剤、注射剤等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。天疱瘡治療の世界市場概観、企業動向、企業別天疱瘡治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分...

世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
世界のセロトニン症候群治療市場予測（～2024年） Serotonin syndrome refers to a group of symptoms and signs caused by the hyperfunction of serotonin in the nervous system, which is manifested as the triad of cognitive function/behavior change, neuromuscular abnormality and autonomic nervous instability. Scope of the Report: The global Serotonin Sy…
世界の慢性リンパ性白血病（CLL）治療市場予測（～2024年） Treatment options for chronic lymphocytic leukemia (CLL) vary greatly, depending on the person’s age, the disease risk group, and the reason for treating (for example, which symptoms it is causing). Scope of the Report: The global Chronic Lymphocytic Leukemia (CLL) Treatment market is valued at xx m…
世界の髄膜炎菌感染症治療市場予測（～2024年） Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality. Scope of the Re…
世界の皮膚線維症治療市場予測（～2024年） Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β,186. This growth factor maybe derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of e…